In addition, the impairment of soluble guanylate-cyclase (sGC) in HF, the enzyme responsible for cyclic guanosine-monophosphate (cGMP) formation, raised interest among scientists who sought to evaluate its power as a new therapeutic target. Here, SGCB is linked to hydrops fetalis.